Rang	Name	Position
1	Dr. Kevin Lee M.B.A., Ph.D.	CEO & Executive Director
2	Dr. Michael Skynner B.sc. Ph.d., Ph.D.	Chief Scientific Officer
3	Mr. Alistair Milnes	Chief Corporate Development Officer
4	Dr. Christian Heinis	Scientific Founder
5	Mr. Travis Thompson	Chief Financial Officer
6	Dr. Jennifer Perry Pharm.D.	Chief Operating Officer
7	Ms. Stephanie Yao	Senior Vice President of Investor Relations and Corporate Communications
8	Mr. Zafar Qadir	Chief Legal Officer & General Counsel
9	Dr. Phil Jeffrey	Senior VP of Pre-Clinical Development
10	Dr. Michael Charles-Ferguson Hannay	Chief Product & Supply Chain Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Baker Bros Advisors LP	15,55%	42,02 Mio. USD
2	FCPM III SERVICES BV	4,96%	13,39 Mio. USD
3	Armistice Capital, LLC	4,85%	13,12 Mio. USD
4	Long Focus Capital Management, LLC	4,73%	12,78 Mio. USD
5	Acadian Asset Management LLC	2,81%	7,60 Mio. USD
6	Siren, L.L.C.	2,23%	6,03 Mio. USD
7	GSK PLC	2,19%	5,90 Mio. USD
8	T. Rowe Price Associates, Inc.	1,47%	3,97 Mio. USD
9	Renaissance Technologies Corp	1,40%	3,78 Mio. USD
10	Morgan Stanley - Brokerage Accounts	0,88%	2,39 Mio. USD
11	Schroder Investment Management Group	0,88%	2,38 Mio. USD
12	Citadel Advisors Llc	0,79%	2,14 Mio. USD
13	Millennium Management LLC	0,79%	2,14 Mio. USD
14	Peapod Lane Capital LLC	0,77%	2,08 Mio. USD
15	Birchview Capital, LP	0,66%	1,79 Mio. USD
16	Diadema Partners LP	0,66%	1,79 Mio. USD
17	Two Sigma Investments LLC	0,62%	1,68 Mio. USD
18	Silvercrest Asset Management Group LLC	0,61%	1,66 Mio. USD
19	Marshall Wace Asset Management Ltd	0,54%	1,46 Mio. USD
20	Qube Research & Technologies	0,44%	1,19 Mio. USD